R&D / product-development studies
Science and regulation, on one platform
An experienced team follows your product through the safety and market-access stages as well. A decision made at authorization stays defensible in the reimbursement dossier.
- 01.1
R&D / product-development studies
Design, planning, execution and reporting of formulation, bioequivalence and drug-development studies. Projects are detailed to include GMP prioritization and clinical / non-clinical reports